Genebox
PrivateLast Round
Series B
Extension
Jul 1, 2026
Total Funding Raised
$18.61M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genebox operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B Extension round in July 2026.
Genebox is a laboratory services (healthcare) company that provides direct-to-consumer genetic testing services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Freemium, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genebox Comparables
Compare Genebox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WeGene | 88% | |
| GeseDNA Technology | 88% | |
| Prenetics | 81% |
For institutional investors. Book with your work email.
Genebox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 1, 2026 | ||||
| Series B | Nov 26, 2025 | ||||
| Series A Extension | Dec 7, 2020 | ||||
| Series A | Oct 9, 2019 | ||||
| Angel | Nov 8, 2018 |
For institutional investors. Book with your work email.
Genebox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centurium Capital | Series B, Series A, Series A Extension |
| SDIC Chuangyi Industrial Fund Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2025
Led by SDIC Chuangyi Industrial Fund Management and Centurium Capital.
- Oct 29, 2024
Monthly visitors grew 251% MoM, reaching 1K.
For institutional investors. Book with your work email.
Genebox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genebox's valuation, stock price, and market status.
Is Genebox a public or private company?
Genebox is a private company.
What is the current stock price of Genebox?
Genebox is a private company, so its shares have no public market price. Caplight tracks Genebox's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genebox worth (valuation)?
Valuation information for Genebox is not publicly available.
Can I buy Genebox stock?
Genebox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genebox's last funding round?
Genebox's most recent funding round was Series B Extension on July 1, 2026.
Who are the main investors in Genebox?
Key investors in Genebox include Centurium Capital, SDIC Chuangyi Industrial Fund Management.
Will Genebox IPO soon?
No public IPO plans have been announced for Genebox.
How can I track Genebox secondary market activity?
Caplight tracks bids, offers, and trades in Genebox's shares on secondary markets.